Government of Canada. Opioid—and Stimulant-Related Harms in Canada. Ottawa, Ontario: Government of Canada. 2022.

Centers for Disease Control and Prevention (CDC). Drug overdose: death rate maps and graphs. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. 2022.

Ahmad FB RL, Sutton P. Provisional drug overdose death counts. National Vital Statistics System, National Center for Health Statistics, Centres for Disease Control and Prevention (CDC). 2022.

Jones CM, Houry D, Han B, Baldwin G, Vivolo-Kantor A, Compton WM. Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Ann N Y Acad Sci. 2022;1508(1):3–22.

Article  CAS  PubMed  Google Scholar 

Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among us adults. JAMA Psychiat. 2021;78(12):1329–42.

Article  Google Scholar 

Jones CM, Compton WM, Mustaquim D. Patterns and characteristics of methamphetamine use among adults—United States, 2015–2018. MMWR Morb Mortal Wkly Rep. 2020;69(12):317–23.

Article  PubMed  PubMed Central  Google Scholar 

Canadian Centre for Substance Use and Addiction (CCSA). Canadian Drug Summary: Methamphetamine. Ottawa, Ontario: Canadian Centre for Substance Use and Addiction (CCSA). 2020.

Jones CM, Underwood N, Compton WM. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17. Addiction. 2020;115(2):347–53.

Article  PubMed  Google Scholar 

Jones CM, Han B, Seth P, Baldwin G, Compton WM. Increases in methamphetamine injection among treatment admissions in the US. Addict Behav. 2023;136: 107492.

Article  PubMed  Google Scholar 

Palamar JJ, Han BH, Keyes KM. Trends in characteristics of individuals who use methamphetamine in the United States, 2015–2018. Drug Alcohol Depend. 2020;213: 108089.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strickland JC, Stoops WW, Dunn KE, Smith KE, Havens JR. The continued rise of methamphetamine use among people who use heroin in the United States. Drug Alcohol Depend. 2021;225: 108750.

Article  PubMed  PubMed Central  Google Scholar 

Strickland JC, Havens JR, Stoops WW. A nationally representative analysis of “twin epidemics”: Rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019;204: 107592.

Article  PubMed  PubMed Central  Google Scholar 

Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14–20.

Article  PubMed  Google Scholar 

Jones CM, Olsen EO, O’Donnell J, Mustaquim D. Resurgent methamphetamine use at treatment admission in the United States, 2008–2017. Am J Public Health. 2020;110(4):509–16.

Article  PubMed  PubMed Central  Google Scholar 

Tardelli VS, Johnstone S, Xu B, et al. Trends in emergency department visits and inpatient admissions related to methamphetamines in Toronto, Canada, 2014–2021. Canadian J Psychiatry. 2022. https://doi.org/10.1177/07067437221125302.

Article  Google Scholar 

Papamihali K, Collins D, Karamouzian M, Purssell R, Graham B, Buxton J. Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services. PLoS ONE. 2021;16(5): e0252090.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez AM, Dhatt Z, Howe M, et al. Co-use of methamphetamine and opioids among people in treatment in Oregon: a qualitative examination of interrelated structural, community, and individual-level factors. Int J Drug Policy. 2021;91: 103098.

Article  PubMed  PubMed Central  Google Scholar 

Silverstein SM, Daniulaityte R, Getz K, Zule W. “It’s crazy what meth can help you do”: lay beliefs, practices, and experiences of using methamphetamine to self-treat symptoms of opioid withdrawal. Subst Use Misuse. 2021;56(11):1687–96.

Article  PubMed  Google Scholar 

Hansen ER, Carvalho S, McDonald M, Havens JR. A qualitative examination of recent increases in methamphetamine use in a cohort of rural people who use drugs. Drug Alcohol Depend. 2021;229: 109145.

Article  PubMed  PubMed Central  Google Scholar 

Palmer A, Scott N, Dietze P, Higgs P. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduct J. 2020;17(1):14.

Article  PubMed  PubMed Central  Google Scholar 

Strang J, Volkow ND, Degenhardt L, et al. Opioid use disorder. Nat Rev Dis Primers. 2020;6(1):3.

Article  PubMed  Google Scholar 

Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. The Lancet. 2019;393(10182):1760–72.

Article  Google Scholar 

Socías ME, Dong H, Wood E, et al. Trajectories of retention in opioid agonist therapy in a Canadian setting. Int J Drug Policy. 2020;77: 102696.

Article  PubMed  PubMed Central  Google Scholar 

Socías ME, Wood E, Kerr T, et al. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006–2016. Drug Alcohol Depend. 2018;189:90–5.

Article  PubMed  PubMed Central  Google Scholar 

Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addict Dis. 2016;35(1):22–35.

Article  PubMed  Google Scholar 

Kurz M, Min JE, Dale LM, Nosyk B. Assessing the determinants of completing OAT induction and long-term retention: a population-based study in British Columbia. Canada J Subst Abuse Treat. 2022;133: 108647.

Article  CAS  PubMed  Google Scholar 

Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP. Update on barriers to pharmacotherapy for opioid use disorders. Curr Psychiatry Rep. 2017;19(6):35.

Article  PubMed  PubMed Central  Google Scholar 

Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. “It’s like ‘liquid handcuffs”: the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients’ lives. Harm Reduct J. 2021;18(1):88.

Article  PubMed  PubMed Central  Google Scholar 

Nosyk B, Marsh DC, Sun H, Schechter MT, Anis AH. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996–2006. J Subst Abuse Treat. 2010;39(1):22–31.

Article  PubMed  Google Scholar 

Peles E, Linzy S, Kreek MJ, Adelson M. One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel. J Addict Dis. 2008;27(4):11–25.

Article  PubMed  Google Scholar 

Saloner B, Whitley P, Dawson E, Passik S, Gordon AJ, Stein BD. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety. Addiction. 2023. https://doi.org/10.1111/add.16180.

Article  PubMed  Google Scholar 

Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract. 2021;16(1):1–25.

Article  Google Scholar 

Krawczyk N, Williams AR, Saloner B, Cerdá M. Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. J Subst Abuse Treat. 2021;126: 108329.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mackay L, Bach P, Milloy M, Cui Z, Kerr T, Hayashi K. The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs. Drug Alcohol Depend. 2021;225: 108844.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsui JI, Mayfield J, Speaker EC, et al. Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. J Subst Abuse Treat. 2020;109:80–5.

Article  PubMed  Google Scholar 

Pilarinos A, Kwa Y, Joe R, et al. Methadone maintenance treatment discontinuation among young people who use opioids in Vancouver. Canada Can J Psychiatry. 2023;68(2):89–100.

Article  PubMed  Google Scholar 

Lo A, Kerr T, Hayashi K, et al. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs. J Subst Abuse Treat. 2018;94:41–6.

Article  PubMed  PubMed Central  Google Scholar 

Liu D, Gu J, Xu H, et al. Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou. China AIDS care. 2017;29(4):458–63.

Article  PubMed  Google Scholar 

Vafaeinasab MR, Farahzadi MH, Razaghi OM, Fallahzadeh RA, Lotfi MH, Akhondzadeh S. Investigation of affecting factors on persistence in the treatment of patients under methadone maintenance therapy in addiction therapy centers, Yazd-Iran. Health. 2015;7(05):606.

Article  Google Scholar 

Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction. 2009;104(5):775–83.

Article  PubMed  Google Scholar 

Gryczynski J, Mitchell SG, Jaffe JH, O’Grady KE, Olsen YK, Schwartz RP. Leaving buprenorphine treatment: patients’ reasons for cessation of care. J Subst Abuse Treat. 2014;46(3):356–61.

Article  PubMed